(Report ID: 84068) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,629 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 5 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 84068 | Jan, 20, 2006 | 41 | Female |
List of drugs the patient takes:
| Drug |
Byetta |
Amaryl |
Actos |
Precose |
List of drug interactions, adverse side effects / events the patient has:
| Name |
Asthenia |
Blood Glucose Decreased |
Blood Glucose Increased |
Dyspepsia |
Fatigue |
Hyperhidrosis |
Stomach Discomfort |
Tremor |
Results from eHealthMe: 5 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Asthenia | 1 (20.00%) |
Blood Glucose Decreased | 1 (20.00%) |
Blood Glucose Increased | 2 (40.00%) |
Dyspepsia | 1 (20.00%) |
Fatigue | 1 (20.00%) |
Hyperhidrosis | 1 (20.00%) |
Stomach Discomfort | 1 (20.00%) |
Tremor | 1 (20.00%) |
2) Top drug interactions, adverse side effects reported for the past 12 months:
3) Top co-used drugs drugs reported for the past 12 months:
4) Top drug interactions, adverse side effects reported of all time:Death: 0 Cancer: 1 (20.00% of total reports)
| Name | Count (% of total reports) |
1 | Blood Glucose Fluctuation | 2 (40.00%) |
2 | Early Satiety | 2 (40.00%) |
3 | Decreased Appetite | 2 (40.00%) |
4 | Blood Glucose Increased | 2 (40.00%) |
5 | Feeling Jittery | 1 (20.00%) |
6 | Dyspnoea | 1 (20.00%) |
7 | International Normalised Ratio Increased | 1 (20.00%) |
8 | Weight Decreased | 1 (20.00%) |
9 | Non-cardiac Chest Pain | 1 (20.00%) |
10 | Injection Site Bruising | 1 (20.00%) |
5) Top co-used drugs drugs reported of all time:
| Name | Count |
1 | Lisinopril | 2 |
2 | Combivent | 2 |
3 | Diovan | 2 |
4 | Nexium | 2 |
5 | Zyrtec | 2 |
6 | Spironolactone | 2 |
7 | Lantus | 2 |
8 | Multi-vitamin | 1 |
9 | Calcium Gluconate | 1 |
10 | Cymbalta | 1 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
Side effects comparison of Plavix (Sanofi Aventis Us) - EQ 75MG ... (Nov, 21, 2008)
|
Dipyridamole (Actavis Totowa) - 75MG for Stroke (Nov, 21, 2008)
|
Prozac (Lilly) - EQ 20MG BASE for Depression (Nov, 21, 2008)
|
Cymbalta (Eli Lilly) - 60MG for Depression (Nov, 20, 2008)
|
Fluconazole (Dr Reddys Labs Inc) - 15... for Candidiasis (Nov, 20, 2008)
|
Yaz (Bayer Hlthcare) - 3MG; 0.02MG for Birth Control (Nov, 20, 2008)
|
Astelin (Meda Pharms) - EQ 0.125MG BA... for Pet Allergies (Nov, 20, 2008)
|
Cyclobenzaprine Hydrochloride (Actavi... for Lower Back Pain (Nov, 20, 2008)
|
Prozac (Lilly) - EQ 40MG BASE for Anxiety (Nov, 20, 2008)
|
Norvasc (Pfizer) - EQ 5MG BASE for BLOOD PRESSURE (Nov, 20, 2008)
|
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|